# STrategic Reperfusion in Elderly Patients Early After Myocardial Infarction

Study · id `cardio:ct-nct02777580` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02777580](<https://clinicaltrials.gov/study/NCT02777580>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02777580

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 609 participants.

## Technical summary

Registry record NCT02777580. Randomized; no masking; primary purpose treatment. Start 2017-08-01 (actual); primary completion 2022-10-13 (actual). Results posted on 2024-10-04.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 609 participants (enrolled count; ClinicalTrials.gov record NCT02777580, source copy `cardio:ctgov-nct02777580-2024-10-04`, retrieved 2026-10-26)
- Started: 2017-08-01 (actual) (ClinicalTrials.gov record NCT02777580, source copy `cardio:ctgov-nct02777580-2024-10-04`, retrieved 2026-10-26)
- Primary completion: 2022-10-13 (actual) (ClinicalTrials.gov record NCT02777580, source copy `cardio:ctgov-nct02777580-2024-10-04`, retrieved 2026-10-26)
- Completion: 2023-09-30 (actual) (ClinicalTrials.gov record NCT02777580, source copy `cardio:ctgov-nct02777580-2024-10-04`, retrieved 2026-10-26)
- Results first posted: 2024-10-04 (ClinicalTrials.gov record NCT02777580, source copy `cardio:ctgov-nct02777580-2024-10-04`, retrieved 2026-10-26)
- Countries: Australia; Brazil; Canada; Chile; France; Mexico; Montenegro; Russia; Serbia; Spain (ClinicalTrials.gov record NCT02777580, source copy `cardio:ctgov-nct02777580-2024-10-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02777580-2024-10-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: STrategic Reperfusion in Elderly Patients Early After Myocardial Infarction
- Acronym: STREAM-2
- Condition: Myocardial Infarction
- Intervention (Drug): Tenecteplase
- Intervention (Drug): Clopidogrel
- Intervention (Procedure): Coronary angiography
- Intervention (Procedure): Primary PCI
- Lead sponsor: KU Leuven
- Lead sponsor class: OTHER
- Collaborator: Boehringer Ingelheim
- Collaborator class: INDUSTRY
- Collaborator: Life Sciences Research Partners
- Collaborator class: OTHER
- Collaborator: Frans Van de Werf Fund for Clinical Cardiovascular Research
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry intervention name matches this record: Tenecteplase (`cardio:tenecteplase`)
- Registry intervention name matches this record: Clopidogrel (`cardio:clopidogrel`)
- Registry lists this organization as the lead sponsor: KU Leuven (`cardio:org-ku-leuven`)
- Registry lists this organization as a collaborator: Boehringer Ingelheim (`cardio:boehringer-ingelheim`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial (`cardio:pubmed-37439219`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: f9c8fcd33045cf84566671aa6d51d91850dade8999e0afbd95762eb0169ad4d1
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
